Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory

Melanoma

Sensitizing 'Cold' Melanomas to Immunotherapies

American Association for Cancer Research
Approximately 40 percent of melanomas lack sufficient infiltration of immune cells within the tumor and therefore have poor responses to immunotherapies